Psychedelic Startups, Biotech, Drug Discovery, Psilocybin, DMT, Psychedelics & Society | Sam Banister | 79
Mind & Matter
00:00
Is This a Subclass of Psychiatry?
More than a hundred companies working on pre clinical and clinical development in this base. There's people really dissecting some of these things at every level of analysis, it seems. A silisibon clearly has clinically demonstrable effects in depression that's been shown. With d m t, that sort of a newer area of study, but i believe there are groups looking at a d m t and five moth oxy d m t. So so wi'll have data from those trials as well, quit soon.
Play episode from 29:45
Transcript
